FDA awards first nod for saliva-based antibody test To view this email as a web page,
click here | | Webinar: New Trends in Virtual Trials Monday, July 26 | 11am ET / 8am PT Last year, clinical trial platform developer Medable raised $91M in private funding, amid the COVID-19 pandemic that touched off huge demand among pharma companies looking to initiate “siteless” or virtual clinical trials. Explore the role of CROs in siteless trials and the opportunities and challenges for CROs to expand their capabilities in this burgeoning area. Register now. |
Pfizer, Moderna COVID-19 vaccines will get label warning over rare heart risk, FDA says FDA greenlights its first saliva-based COVID-19 antibody test House bill seeks to raise reimbursement for rural hospitals in bid to close payment disparity COVID-19 tracker: WHO predicts yearly boosters for most vulnerable: report Featured Story | By Kevin Dunleavy The FDA says it will move quickly to add a label warning about heart inflammation risks with the COVID-19 vaccines from Pfizer and Moderna. The CDC reports 309 hospitalizations linked to the rare risk, mostly among males aged 16 to 24, with no deaths. read more |
| |
|---|
|
Top Stories By Conor Hale The FDA authorized its first antibody test that doesn’t use blood samples to check for evidence of a COVID-19 infection and instead relies on simple, painless mouth swabs. Developed by Diabetomics, the diagnostic is now allowed for used at the point of care for adults and children and delivers a result within 15 minutes. read more By Robert King A new House bill aims to raise the Medicare reimbursement for rural hospitals in an effort to close a pay disparity with urban facilities. read more By Noah Higgins-Dunn,Kevin Dunleavy,Fraiser Kansteiner The World Health Organization expects those most vulnerable to the coronavirus and troublesome variants will likely need yearly booster shots, while everyone else may need them every other year, Reuters reports. The FDA approved the first antibody test that doesn't require a blood sample. And more headlines. read more | | Webinar: COVID-19 Virus Sequencing for Drug Development Wednesday, July 28 | 10:30am ET / 7:30am PT As new COVID-19 variants continue to emerge, virus sequencing will play critical and ongoing role in drug and vaccine development. This webinar will connect insights from population surveillance to potential solutions for drug developers, outline approaches to COVID-19 virus sequencing and more. Register Now. |
|
|
